Perspective Therapeutics IncCATX
Price$2.72

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $76KTTM through 30 Jun 2026
Net Income -$116.4MTTM through 30 Jun 2026
Free Cash Flow -$121.2MTTM through 30 Jun 2026

Margins

Current
Operating Margin-37,268.0%
Net Margin-34,459.0%

Returns

-36.0%ROE
-27.0%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio8.75x
Net Debt-$269.3Mnet cash position
Cash & Equivalents$48.5M

Quality Metrics

Altman Z-Score1.16
Piotroski F-Score1 / 9
FCF Margin-159,456.6%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'18'19'20'21'22'22'23
FY2023: $1.4M
Diluted EPS-$1.33TTM
'23'24'25
FY2025: $-1.40

Dividend

No dividend

Capital Allocation

Capex Intensity37,000.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.